1.Tissue Plasminogen Activator and Plasminogen Activator Inhibitor Type 1 Gene Polymorphism in Patients with Gastric Ulcer Complicated with Bleeding.
Hong Soo KIM ; Kyu Yoon HWANG ; Il Kwon CHUNG ; Sang Heum PARK ; Moon Ho LEE ; Sun Joo KIM ; Sae Yong HONG
Journal of Korean Medical Science 2003;18(1):58-64
Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1) may be involved in the pathogenesis of peptic ulcers through suppression of fibrinolysis. This study was designed to investigate associations of t-PA and PAI-1 genes with clinical features of the patients with bleeding gastric ulcers. Eighty-four patients with peptic ulcers and 100 controls were studied between January 1998 and April 2000. We used polymerase chain reaction and endonuclease digestion to genotype for 4G/5G polymorphism in the promoter region of the PAI-1 gene and the Alurepeat insertion/deletion (I/D) polymorphism in intron h of the t-PA gene. Various clinical features, including lesion site, bleeding event, recurrence of ulcer, and rebleeding, were assessed using a multiple logistic regression model. The genotype distributions of both the t-PA and PAI-1 genes did not differ between the patient and control groups. The occurrence of the I/D or D/D genotype of t-PA was significantly higher in cases of duodenal ulcer (adjusted OR=4.39, 95% CI=1.12-17.21). When a dominant effect (i.e., 4G/4G or 4G/5G versus 5G/5G) of the 4G allele was assumed, the PAI-1 4G/4G genotype was independently associated with rebleeding after hemostasis (adjusted OR=5.07, 95% CI=1.03-24.87). Our data suggest that t-PA gene polymorphism is associated with duodenal ulcers, and that the PAI-1 gene may be a risk factor leading to recurrent bleeding after initial hemostasis.
Adult
;
Aged
;
Alu Elements/genetics
;
DNA Mutational Analysis
;
Duodenal Ulcer/complications
;
Duodenal Ulcer/genetics*
;
Female
;
Gene Frequency
;
Genetic Predisposition to Disease
;
Genotype
;
Human
;
Male
;
Middle Aged
;
Mutagenesis, Insertional
;
Peptic Ulcer Hemorrhage/etiology
;
Peptic Ulcer Hemorrhage/genetics*
;
Plasminogen Activator Inhibitor 1/genetics*
;
Polymorphism (Genetics)*
;
Promoter Regions (Genetics)/genetics
;
Recurrence
;
Sequence Deletion
;
Stomach Ulcer/complications
;
Stomach Ulcer/genetics*
;
Tissue Plasminogen Activator/genetics*
2.A Case of CD56+ Extranodal NK/T-cell Lymphoma, Nasal Type, Presenting as a Duodenal Ulcer Bleeding.
Ji Hee YU ; Kee Don CHOI ; Young Wha KOH ; Won Jung CHOI ; Ho June SONG ; Gin Hyug LEE ; Hwoon Yong JUNG ; Jin Ho KIM
The Korean Journal of Gastroenterology 2009;54(3):174-179
Extranodal NK/T-cell lymphoma is a recently recognized distinct entity within the World Health Organization classification of lymphoid tumors. It is relatively prevalent in Asian and South American populations. It most commonly occurs in the nasal or paranasal areas and less frequently in the skin, the soft tissue, and the gastrointestinal tract. Among these, extranodal NK/T-cell lymphoma of the gastrointestinal tract has shown an aggressive clinical course. We report a case of CD56+ extranodal NK/T-cell lymphoma presenting as a duodenal ulcer bleeding. A 62-year-old male patient presented with melena and abdominal pain. Endoscopic examination of the upper gastrointestinal tract showed the duodenal ulcer covered by blood clot. Pathologic examination revealed the diffuse infiltration of atypical lymphocytes with an angiocentric growth pattern, which was positive for CD3, CD56, and granzyme. The patient showed rapid deteriorating clinical course and died on day 14 after admission. Thus, we report this case with the review of literatures.
Antigens, CD3/metabolism
;
Antigens, CD56/*metabolism
;
Bone Marrow/pathology
;
Duodenal Ulcer/*diagnosis
;
Herpesvirus 4, Human/genetics/metabolism
;
Humans
;
Lymphoma, Extranodal NK-T-Cell/*diagnosis/pathology
;
Male
;
Middle Aged
;
Peptic Ulcer Hemorrhage/*diagnosis
;
Tomography, X-Ray Computed